BioCentury | Oct 21, 2019
Emerging Company Profile

Verseau unveils tumor macrophage reprogramming strategy

...collaboration project. Verseau’s investor syndicate includes 20/20 HealthCare Partners, 3SBio, Alexandria Venture Investments, Highlight Capital, InHarv Partners Ltd....
...Funds raised: $50 million Investors: 20/20 HealthCare Partners, 3SBio Inc., Alexandria Venture Investments, Highlight Capital, InHarv Partners Ltd....
Items per page:
1 - 1 of 1
BioCentury | Oct 21, 2019
Emerging Company Profile

Verseau unveils tumor macrophage reprogramming strategy

...collaboration project. Verseau’s investor syndicate includes 20/20 HealthCare Partners, 3SBio, Alexandria Venture Investments, Highlight Capital, InHarv Partners Ltd....
...Funds raised: $50 million Investors: 20/20 HealthCare Partners, 3SBio Inc., Alexandria Venture Investments, Highlight Capital, InHarv Partners Ltd....
Items per page:
1 - 1 of 1